Oppenheimer Downgrades Corcept Therapeutics (CORT) to Perform
Oppenheimer downgraded Corcept Therapeutics (NASDAQ: CORT) from Outperform to Perform following Q3 results.
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $2.24 yesterday, with a 52 week range of $2.23-$4.90.
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $2.24 yesterday, with a 52 week range of $2.23-$4.90.